<DOC>
	<DOC>NCT01361620</DOC>
	<brief_summary>The study seeks to identify genomic markers associated with aspirin resistance.</brief_summary>
	<brief_title>Genotypic and Phenotypic Correlates of Resistance to Aspirin</brief_title>
	<detailed_description>Not desired</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Volunteers 40 to 80 years old willing to sign consent and take 81 mg of aspirin for 7 10 days and return for laboratory testing. Patient requiring more than 81 mg aspirin daily Known GI bleeding attributed to ASA Active peptic ulcer disease or history within the last year Known aspirin allergy Current use of: warfarin, heparin, NSAIDs (except aspirin), clopidogrel, dipyridamole, fishoil/omega 3 supplements, Women of childbearing potential who are pregnant, planning to become pregnant or nursing.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>genomic markers</keyword>
	<keyword>aspirin resistance</keyword>
</DOC>